Anti-p200 pemphigoid: A multi-institutional North American case series of 47 patients with clinical, serologic, and histopathologic data
This article describes clinical, serologic, and histopathologic features of the first North American cohort of patients with positive anti-p200 serology identified at Mayo Clinic, Rochester, Minnesota, USA and Beutner Laboratories, Buffalo, New York, USA. Forty-seven patients were identified with positive p200 laminin beta 4 autoantibodies, detected with either immunoglobulin (Ig)G or IgG4 modified indirect immunofluorescence on HEK293 cells transfected with recombinant laminin beta.
Authors
- Anatilde González Guerrico
- Julia Scott Lehman (ORCID: https://orcid.org/0000-0002-7389-3853)
- Lakshmanan Suresh (ORCID: https://orcid.org/0000-0003-3894-1271)
- Lindsey J Wanberg (ORCID: https://orcid.org/0000-0002-6052-5613)
- Shruti Agrawal (ORCID: https://orcid.org/0000-0003-0123-432X)
- Carly J Shore
- Donna Culton
- Raminder Grover
- Michael J Camilleri
Institutions
- University of North Carolina at Chapel Hill (US)
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- King Center Charter School (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-08-17
- DOI
- https://doi.org/10.1093/bjd/ljag339
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00